Pulse Biosciences (PLSE) Non-Current Deffered Revenue (2017 - 2018)

Pulse Biosciences' (PLSE) quarterly Non-Current Deffered Revenue came in at $1.2 million in Q4 2018, down 25.73% year-on-year from $1.6 million in Q4 2017, and down 8.13% quarter-over-quarter from $1.3 million in Q3 2018.

Pulse Biosciences (PLSE) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends

Pulse Biosciences' Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $1.2 million for Q4 2018.

  • On a quarterly basis, Non-Current Deffered Revenue fell 25.73% year-over-year to $1.2 million in Q4 2018; TTM through Dec 2018 was $1.2 million, a 25.73% decrease from a year earlier, with the FY2018 full-year figure at $1.2 million, down 25.73% from the prior year.
  • Non-Current Deffered Revenue slipped to $1.2 million in Q4 2018 per PLSE's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $1.8 million in Q2 2017 and bottomed at $1.2 million in Q4 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 163.15 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 13.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 208.80 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Pulse Biosciences 2.09 Bn 2.01 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 1.20 Mn
Sep 30, 2018 1.30 Mn
Jun 30, 2018 1.41 Mn
Mar 31, 2018 1.51 Mn
Dec 31, 2017 1.61 Mn
Sep 30, 2017 1.72 Mn
Jun 30, 2017 1.82 Mn